Invitrogen™ Human CD34 ELISA Kit

Ref.: BL-RE-106862Manufacturer ref.: EH86RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human CD34 quantitates human CD34 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD34.

Accession number
AU040960; Cd34; CD34 antigen; CD34 molecule; group 34 designation; group 34 differentiation antigen; CD34 hematopoietic stem cell antigen; CD34 hematopoietic stem cell marker; LOC100343670; mucosialine; RP11-328D5.2
Dose range
0.05 to 10 ng/ml
Sensitivity of the dosage
0.05 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human CD34 quantitates human CD34 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD34.

Human CD34 quantitates human CD34 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD34.

CD34 is a highly glycosylated monomer with a molecular weight range of 111-115 kDa of surface proteins present in many stem cell populations. CD34 is a stem cell marker, although its expression on human hematopoietic stem cells is reversible. CD34 can be used as a surface receptor that undergoes receptor-mediated endocytosis and regulates adhesion, differentiation and proliferation of hematopoietic stem cells and other progenitors. CD34 expression is likely to represent a specific state of haematopoietic development that may have altered adherence properties with expansion and differentiation capabilities under in vitro and in vivo conditions. CD34 may be a adhesion molecule with a putative role for mediating stem cell attachment to the extracellular bone marrow matrix or directly to the stromal cells. In addition, CD34 could be used as scaffolding for adherence to line-specific glycanes, allowing stem cells to bind to lectins expressed by stromal cells or other components of the marrow. CD34 is thought to play a role in presenting carbohydrate ligands to selectins. The CD34 antigen intracellular chain is a site of activated protein kinase C phosphorylation, suggesting a putative role in signal transduction. Diseases associated with CD34 dysfunction include dermatofibrosarcoma and neurofibroma.

Sensitivity

Sensitivity of the dosage: 0.05 ng/ml.

Measurement range

Dosing range: 0.05 to 10 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CD34.

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17165319
Specifications
Accession numberAU040960; Cd34; CD34 antigen; CD34 molecule; group 34 designation; group 34 differentiation antigen; CD34 hematopoietic stem cell antigen; CD34 hematopoietic stem cell marker; LOC100343670; mucosialine; RP11-328D5.2
Dose range0.05 to 10 ng/ml
Sensitivity of the dosage0.05 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P28906
Gene symbol(s)Cd34
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetCD34
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH86RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.